Innovestor

Type

Venture Capital, Accelerator/Incubator

Status

Active

Location

Helsinki, Finland

Total investments

60

Average round size

2M

Portfolio companies

49

Rounds per year

6.00

Lead investments

28

Follow on index

0.18

Exits

1

Stages of investment
Private EquityEarly Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyMobileHealth CareSaaSManufacturingMedical DeviceMedicalElectronics

Summary

Innovestor appeared to be the VC, which was created in 2014. The leading representative office of defined VC is situated in the Helsinki. The company was established in Europe in Finland.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Innovestor, startups are often financed by Finnvera Venture Capital, Tekes, VTT Ventures. The meaningful sponsors for the fund in investment in the same round are Visionplus, Lifeline Ventures, Yahoo! Japan. In the next rounds fund is usually obtained by Way to Wellville, Visionplus, Vesalius Biocapital Partners.

The current fund was established by Tommi u00c4iju00e4lu00e4. We also calculated 14 valuable employees in our database.

The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The typical startup value when the investment from Innovestor is 5-10 millions dollars. This Innovestor works on 26 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 60 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars.

Among the most popular portfolio startups of the fund, we may highlight Linkker, Tenboron, LNGTainer. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Finland. Among the most successful fund investment fields, there are Biotechnology, Software.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesHealthcareManufacturingB2B/Enterprise
Stage focus
Series APre-SeedSeed
Geo focus
DenmarkEstoniaFinlandIcelandLatvia Show 3 more
Check size
268K — 3M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 30000000
Fund raised date
2023-12-12

Analytics

Total investments
60
Lead investments
28
Exits
1
Rounds per year
6.00
Follow on index
0.18
Investments by industry
  • Software (10)
  • Electronics (8)
  • Information Technology (8)
  • Health Care (7)
  • Manufacturing (7)
  • Show 84 more
Investments by region
  • Finland (51)
  • Denmark (4)
  • Sweden (2)
  • United States (2)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
826K
Group Appearance index
0.43
Avg. company exit year
4

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Confidentialmind 21 Jun 2024 Machine Learning, Enterprise Software Seed 1M Espoo, Southern Finland, Finland
HVR Cardio 11 Jan 2023 Health Care, Health Diagnostics Early Stage Venture 12M Espoo, Southern Finland, Finland

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.